VRM Molecular and Nuclear Medicines Private Limited
About VRM Molecular and Nuclear Medicines Private Limited
Data last updated:
VRM Molecular and Nuclear Medicines Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 05 February 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U21002MP1996PTC010463. Its GSTIN is 23AABCV2442B1Z0 (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.46 Lakh. It is led by directors including Manjushree Bhandari and Mohit Bhandari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 – G F – Scheme No.54 Opp.Meghdoot Garden, Indore, Madhya Pradesh, India.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹62 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
VRM Molecular and Nuclear Medicines has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U21002MP1996PTC010463, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21002MP1996PTC010463 | Current |
| U85110MP1996PTC010463 | Previous |
| U66010MP1996PTC010463 | Previous |
Contact details
VRM Molecular and Nuclear Medicines Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 – G F – Scheme No.54 Opp.Meghdoot Garden, Indore, Madhya Pradesh, India
- IndustryHealthcare, Preventive Health Services
To see the full contact details of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of VRM Molecular and Nuclear Medicines Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
Board of directors of VRM Molecular and Nuclear Medicines Private Limited
VRM Molecular and Nuclear Medicines has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjushree Bhandari | Director | 05 Feb 1996 | 30 Years 9 Months | Current |
| Mohit Bhandari Also directs: Bhandari Group of Hospitals and Institutions, Bhandari Hospital & Research Centre Pvt. Ltd., Bhandari Ms Associates LLP and 3 more | Director | 12 Aug 2014 | 12 Years 3 Months | Current |
| Mohd Daud Also directs: Id Consultancy Solutions Private Limited | Director | 01 Dec 2025 | 0 Years 11 Months | Current |
| Purushottam Das Vaishya | Director | 13 Jun 2024 | 2 Years 5 Months | Current |
Auditor
VRM Molecular and Nuclear Medicines Private Limited is audited by SANJAY MEHTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY MEHTA & ASSOCIATES | FY 2023 | 011524C |
Shareholding
The shareholding of VRM Molecular and Nuclear Medicines Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2025 | 101141758 | Hdfc Bank Limited | ₹62 Cr | Open |
To see the full charge records of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving VRM Molecular and Nuclear Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VRM Molecular and Nuclear Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
VRM Molecular and Nuclear Medicines Private Limited has a workforce of 6 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 6 |
| FY 2025-26 |
To see the full employee and EPFO history of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
GST
VRM Molecular and Nuclear Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCV2442B1Z0 | Madhya Pradesh | Active | 12 Sep 2024 |
To see the full GST registrations and return filing status of VRM Molecular and Nuclear Medicines Private Limited, buy the company report.
Recent activity
VRM Molecular and Nuclear Medicines Private Limited has 8 board changes on record since 1996: 4 appointments and 4 cessations. The latest: Mohd Daud was appointed as Director on 01 Dec 2025.
1 earlier event is in the company report.
Frequently asked questions
VRM Molecular and Nuclear Medicines is an active private limited company based in Indore, Madhya Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 05 February 1996 (30+ years old) and is registered under CIN U21002MP1996PTC010463.
VRM Molecular and Nuclear Medicines has 4 current directors:
- Manjushree Bhandari - Director
- Mohit Bhandari - Director
- Mohd Daud - Director
- Purushottam Das Vaishya - Director
The latest financial statements of VRM Molecular and Nuclear Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VRM Molecular and Nuclear Medicines is 23AABCV2442B1Z0, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of VRM Molecular and Nuclear Medicines is U21002MP1996PTC010463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VRM Molecular and Nuclear Medicines was incorporated on 05 February 1996, making it 30+ years old. It is registered with the Registrar of Companies, Gwalior.
Mohd Daud was appointed as Director on 01 Dec 2025. Danish Suleman ceased to be Additional Director on 29 Sep 2024. Purushottam Das Vaishya ceased to be Additional Director on 29 Sep 2024. VRM Molecular and Nuclear Medicines has 8 board changes on record in total.
The registered office of VRM Molecular and Nuclear Medicines is at 21 – G F – Scheme No.54 Opp.Meghdoot Garden, Indore, Madhya Pradesh, India.
VRM Molecular and Nuclear Medicines operates in the healthcare industry, in the preventive health services segment.
VRM Molecular and Nuclear Medicines has open charges of ₹62 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
